Intramuscular Hpv Vaccination Market Regulatory Framework and Schedule Evolution
The regulatory landscape for intramuscular HPV vaccination has evolved significantly since the first licensure in 2006, with expanding age indications, schedule simplifications, and gender-neutral recommendations transforming market dynamics and public health impact. The U.S. Food and Drug Administration approved Gardasil 9 for females aged 9-26 in 2014, subsequently expanding to males aged...
0 Yorumlar 0 hisse senetleri 87 Views 0 önizleme